NEW YORK, May 13 (GenomeWeb News) - Agencourt Bioscience, of Beverly, Mass., has licensed pre-validated SNP sequencing assays for kinases from Dana-Farber Cancer Institute, the company said today.
Kinases are implicated in a variety of human diseases, particularly cancer. The sequencing assays, which were developed in the laboratories of Dana-Farber cancer researchers Matthew Meyerson and William Sellers, will be offered as part of Agencourt's SNP discovery service for kinases. The company said that the service will allow analysis of kinase SNPs for "over 92 genes."
Financial terms of the agreement were not disclosed.